Archive for the ‘sage’ Category
Taiwan’s education minister, Chiang Wei-ling, whose name appeared on several of 60 retracted articles by Peter Chen — apparently the architect of a peer review and citation syndicate we were first to report on last week — has resigned over the publishing scandal.
This one deserves a “wow.”
SAGE Publishers is retracting 60 articles from the Journal of Vibration and Control after an investigation revealed a “peer review and citation ring” involving a professor in Taiwan.
[Please see an update on this post.]
That’s a lesson a group of researchers in Italy was forced to learn the hard way. They lost their 2013 article in Medicine, Science and the Law for being too similar to a 2008 paper by different authors in another journal.
According to the abstract: Read the rest of this entry »
This one’s a little circular: The Annals of Pharmacotherapy, a SAGE journal, has retracted an author’s response to a letter to the editor that was never published. The original paper, “Intravenous sodium bicarbonate therapy in severely acidotic diabetic ketoacidosis,” is unaffected by the retraction.
According to the notice: Read the rest of this entry »
The Journal of Evidence-Based Complementary Medicine (JEBCAM) has retracted a 2013 review on probiotics by an author from Turkey who patched the paper together from a variety of other sources — and then appears to have reused his own work elsewhere without attribution.
Former U.S. vice presidential candidate and Alaska governor Sarah Palin is no stranger to retractions, or perhaps “walk backs,” as politicians usually call them. There was her apology for comments about Pope Francis, a clarification about comments thought to be directed at Rush Limbaugh, and a walk back on her behalf from her running mate, Sen. John McCain.
The title of this post is the title of a new commentary in Administrative Science Quarterly by Gerald Davis of the University of Michigan. Its abstract:
Read the rest of this entry »
The authors of a recent paper in the European Journal of Preventive Cardiology on nut intake and the risk of high blood pressure and diabetes have pulled their article from publication for an undisclosed conflict of interest.
Now, you wouldn’t know this unless you were willing to pony up the $32 to read the notice, which is behind a pay wall — something that drives us, well, nuts. But here it is: